Company Filing History:
4 out of 9 
2 out of 2 
1 out of 3 Years Active: 2009-2020
Title: The Innovations of Inventor Annamari Ranki
Introduction
Annamari Ranki, a distinguished inventor based in Helsinki, Finland, has made significant contributions to the field of biotechnology through her innovative research and development. With a portfolio boasting 9 patents, her work primarily focuses on monoclonal antibodies that target specific immune responses associated with various diseases.
Latest Patents
Among her latest patents, two notable inventions are centered around nucleic acid molecules encoding monoclonal antibodies specific for IL-17F and IL-22. These patents describe novel binding molecules of human origin, including human antibodies along with their fragments, derivatives, and variants. These inventions recognize antigens related to immune responses, autoimmune disorders, inflammatory diseases, metabolic disorders, vascular functions, neurodegenerative diseases, and tumors. The patents also highlight the development of a human Auto-Immunosome and a corresponding monoclonal antibody reservoir, alongside pharmaceutical compositions, kits, and methods for use in diagnosis and therapy.
Career Highlights
Annamari has held influential positions in notable companies such as Immunoqure AG and Fit Biotech Oyj Plc. Her expertise and innovation have been instrumental in advancing the scientific understanding and therapeutic applications of monoclonal antibodies, significantly impacting the medical field.
Collaborations
Throughout her career, Annamari Ranki has collaborated with esteemed professionals in her field, including colleagues like Kai Krohn and Adrian Hayday. These partnerships have fostered a collaborative environment that has led to groundbreaking advancements in her research.
Conclusion
Annamari Ranki continues to pave the way for innovations in biomedical science with her exemplary work on monoclonal antibodies. Her contributions not only advance the scientific community's understanding of immune responses but also open avenues for therapeutic interventions in various diseases, showcasing her as a leading inventor in her domain.